Clinical/Translational Cancer Immunotherapy

Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer
Jonathan Anker, Sumanta K Pal, Seunghee Kim-Schulze, Huan Wang, Rebecca Halperin, Andrew Uzilov, Naoko Imai, Shingo Eikawa, Takuro Saito, Robert Sebra, Noah M Hahn, Manishkumar Patel, Jingjing Qi, Hui Xie, Nina Bhardwaj, Sacha Gnjatic, Matthew D Galsky

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e007613; DOI: 10.1136/jitc-2023-007613
Tislelizumab plus chemotherapy for patients with EGFR-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy
Hua Zhong, Xueyan Zhang, Panwen Tian, Tianqing Chu, Qisen Guo, Xinmin Yu, Zhuang Yu, Yalun Li, Lijuan Chen, Jie Liu, Yan Zhang, Yan Guan, Xun Shi, Jing Wang, Yanqiu Zhao, Baohui Han

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e006887; DOI: 10.1136/jitc-2023-006887
Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma
Neslihan Arife Kaya, David Tai, Xinru Lim, Jia Qi Lim, Mai Chan Lau, Denise Goh, Cheryl Zi Jin Phua, Felicia Yu Ting Wee, Craig Ryan Joseph, Jeffrey Chun Tatt Lim, Zhen Wei Neo, Jiangfeng Ye, Lawrence Cheung, Joycelyn Lee, Kelvin S H Loke, Apoorva Gogna, Fei Yao, May Yin Lee, Timothy Wai Ho Shuen, Han Chong Toh, Axel Hilmer, Yun Shen Chan, Tony Kiat-Hon Lim, Wai Leong Tam, Su Pin Choo, Joe Yeong, Weiwei Zhai

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e007106; DOI: 10.1136/jitc-2023-007106
CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression
Kristan Meetze, Naveen K Mehta, Bochong Li, Hannah M Findlay, Timothy B London, Agapitos Patakas, Jennifer S Michaelson, Patrick A Baeuerle

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e007398; DOI: 10.1136/jitc-2023-007398
A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma
Christopher Cultrara, Christopher Uhl, Kenneth Kirby, Essam Abed Elrazaq, Amelia Zellander, David W Andrews, Charles B Scott, Lorenzo Galluzzi, Mark A Exley, Jenny Zilberberg

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e006880; DOI: 10.1136/jitc-2023-006880
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records
Mathilde Beaufils, Vincent Amodru, Manuel Tejeda, Jean Marie Boher, Christophe Zemmour, Brice Chanez, Anne Sophie Chrétien, Laurent Gorvel, Gwenaelle Gravis, Damien Bruyat, Roxane Mari, Anne Madroszyk, Thomas Cuny, Anthony Gonçalves, Aaron E Lisberg, Daniel Olive, Louis Tassy, Frederic Castinetti, Philippe Rochigneux

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e006786; DOI: 10.1136/jitc-2023-006786
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
Jennifer M Johnson, Ioannis A Vathiotis, Larry A Harshyne, Ayesha Ali, Voichita Bar Ad, Rita Axelrod, Emily Lorber, Joseph Curry, David M Cognetti, Adam J Luginbuhl, Madalina Tuluc, Scott Keith, Mỹ G Mahoney, Athanassios Argiris

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e007141; DOI: 10.1136/jitc-2023-007141
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial
Michelle V Dietz, Katrien L A Quintelier, Job P van Kooten, Nadine L de Boer, Madelief Vink, Alexandra R M Brandt-Kerkhof, Cornelis Verhoef, Yvan Saeys, Joachim G J V Aerts, Marcella Willemsen, Sofie Van Gassen, Eva V E Madsen

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e007070; DOI: 10.1136/jitc-2023-007070
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis
Elizabeth Lee Carpenter, Spencer Van Decar, Alexandra M Adams, Anne E O’Shea, Patrick McCarthy, Robert Connor Chick, Guy Travis Clifton, Timothy Vreeland, Franklin A Valdera, Ankur Tiwari, Diane Hale, Phillip Kemp Bohan, Annelies Hickerson, Todd Smolinsky, Katryna Thomas, Jessica Cindass, John Hyngstrom, Adam C Berger, James Jakub, Jeffrey J Sussman, Montaser F Shaheen, Xianzhong Yu, Thomas E Wagner, Mark Faries, George E Peoples

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e006665; DOI: 10.1136/jitc-2023-006665
Carbohydrate ligand engagement with CD11b enhances differentiation of tumor-associated myeloid cells for immunotherapy of solid cancers
Veronique Roche, Victor Sandoval, Claire Wolford, Zachary Senders, Julian Anthony Kim, Susan Pereira Ribeiro, Alex Yicheng Huang, Rafick-Pierre Sekaly, Joshua Lyons, Mei Zhang

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006205; DOI: 10.1136/jitc-2022-006205

Main menu

Clinical/Translational Cancer Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Clinical/Translational Cancer Immunotherapy

Pages